These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Role of synectin in lymphatic development in zebrafish and frogs. Hermans K; Claes F; Vandevelde W; Zheng W; Geudens I; Orsenigo F; De Smet F; Gjini E; Anthonis K; Ren B; Kerjaschki D; Autiero M; Ny A; Simons M; Dewerchin M; Schulte-Merker S; Dejana E; Alitalo K; Carmeliet P Blood; 2010 Oct; 116(17):3356-66. PubMed ID: 20631376 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-126a Directs Lymphangiogenesis Through Interacting With Chemokine and Flt4 Signaling in Zebrafish. Chen J; Zhu RF; Li FF; Liang YL; Wang C; Qin YW; Huang S; Zhao XX; Jing Q Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2381-2393. PubMed ID: 27789478 [TBL] [Abstract][Full Text] [Related]
32. Development of the zebrafish lymphatic system requires VEGFC signaling. Küchler AM; Gjini E; Peterson-Maduro J; Cancilla B; Wolburg H; Schulte-Merker S Curr Biol; 2006 Jun; 16(12):1244-8. PubMed ID: 16782017 [TBL] [Abstract][Full Text] [Related]
33. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. Xu Y; Yuan L; Mak J; Pardanaud L; Caunt M; Kasman I; Larrivée B; Del Toro R; Suchting S; Medvinsky A; Silva J; Yang J; Thomas JL; Koch AW; Alitalo K; Eichmann A; Bagri A J Cell Biol; 2010 Jan; 188(1):115-30. PubMed ID: 20065093 [TBL] [Abstract][Full Text] [Related]
34. Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain. Roukens MG; Peterson-Maduro J; Padberg Y; Jeltsch M; Leppänen VM; Bos FL; Alitalo K; Schulte-Merker S; Schulte D Circ Res; 2015 May; 116(10):1660-9. PubMed ID: 25814692 [TBL] [Abstract][Full Text] [Related]
35. Svep1 is a binding ligand of Tie1 and affects specific aspects of facial lymphatic development in a Vegfc-independent manner. Hußmann M; Schulte D; Weischer S; Carlantoni C; Nakajima H; Mochizuki N; Stainier DYR; Zobel T; Koch M; Schulte-Merker S Elife; 2023 Apr; 12():. PubMed ID: 37097004 [TBL] [Abstract][Full Text] [Related]
36. Atypical E2fs control lymphangiogenesis through transcriptional regulation of Ccbe1 and Flt4. Weijts BG; van Impel A; Schulte-Merker S; de Bruin A PLoS One; 2013; 8(9):e73693. PubMed ID: 24069224 [TBL] [Abstract][Full Text] [Related]
37. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model. Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638 [TBL] [Abstract][Full Text] [Related]
38. Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas. Dumond A; Montemagno C; Vial V; Grépin R; Pagès G Cells; 2021 May; 10(5):. PubMed ID: 34067671 [TBL] [Abstract][Full Text] [Related]
39. VEGFC/FLT4-induced cell-cycle arrest mediates sprouting and differentiation of venous and lymphatic endothelial cells. Jerafi-Vider A; Bassi I; Moshe N; Tevet Y; Hen G; Splittstoesser D; Shin M; Lawson ND; Yaniv K Cell Rep; 2021 Jun; 35(11):109255. PubMed ID: 34133928 [TBL] [Abstract][Full Text] [Related]
40. MiR-128-3p directly targets VEGFC/VEGFR3 to modulate the proliferation of lymphatic endothelial cells through Ca Zhou J; He Z; Guo L; Zeng J; Liang P; Ren L; Zhang M; Zhang P; Huang X Int J Biochem Cell Biol; 2018 Sep; 102():51-58. PubMed ID: 29777777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]